CA1282077C - Process for producing substituted-phenethylamine derivatives - Google Patents
Process for producing substituted-phenethylamine derivativesInfo
- Publication number
- CA1282077C CA1282077C CA000515041A CA515041A CA1282077C CA 1282077 C CA1282077 C CA 1282077C CA 000515041 A CA000515041 A CA 000515041A CA 515041 A CA515041 A CA 515041A CA 1282077 C CA1282077 C CA 1282077C
- Authority
- CA
- Canada
- Prior art keywords
- group
- compound
- salt
- lower alkyl
- hydrogen atom
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 title claims abstract description 39
- -1 substituted-phenethylamine Chemical class 0.000 title claims description 36
- 150000001875 compounds Chemical class 0.000 claims abstract description 39
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 15
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 13
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 10
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 6
- 150000003839 salts Chemical class 0.000 claims description 26
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 12
- 125000003172 aldehyde group Chemical group 0.000 claims description 10
- IORITYIZDHJCGT-UHFFFAOYSA-N 5-(2-aminopropyl)-2-methoxybenzenesulfonamide Chemical compound COC1=CC=C(CC(C)N)C=C1S(N)(=O)=O IORITYIZDHJCGT-UHFFFAOYSA-N 0.000 claims description 5
- IORITYIZDHJCGT-SSDOTTSWSA-N 5-[(2r)-2-aminopropyl]-2-methoxybenzenesulfonamide Chemical compound COC1=CC=C(C[C@@H](C)N)C=C1S(N)(=O)=O IORITYIZDHJCGT-SSDOTTSWSA-N 0.000 claims description 5
- 125000003277 amino group Chemical group 0.000 claims description 3
- DRHKJLXJIQTDTD-UHFFFAOYSA-N 5-(2-{[2-(2-ethoxyphenoxy)ethyl]amino}propyl)-2-methoxybenzenesulfonamide Chemical compound CCOC1=CC=CC=C1OCCNC(C)CC1=CC=C(OC)C(S(N)(=O)=O)=C1 DRHKJLXJIQTDTD-UHFFFAOYSA-N 0.000 claims description 2
- 125000006239 protecting group Chemical group 0.000 claims description 2
- BHHGXPLMPWCGHP-UHFFFAOYSA-N Phenethylamine Chemical class NCCC1=CC=CC=C1 BHHGXPLMPWCGHP-UHFFFAOYSA-N 0.000 abstract description 6
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 206010007559 Cardiac failure congestive Diseases 0.000 abstract description 2
- 206010019280 Heart failures Diseases 0.000 abstract description 2
- 239000002220 antihypertensive agent Substances 0.000 abstract description 2
- 229940030600 antihypertensive agent Drugs 0.000 abstract description 2
- 239000003795 chemical substances by application Substances 0.000 abstract description 2
- 230000000903 blocking effect Effects 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 61
- 238000006243 chemical reaction Methods 0.000 description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 15
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 15
- 238000002844 melting Methods 0.000 description 15
- 230000008018 melting Effects 0.000 description 15
- 239000002904 solvent Substances 0.000 description 15
- 239000000203 mixture Substances 0.000 description 14
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 13
- 238000010438 heat treatment Methods 0.000 description 10
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 8
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 7
- 239000013078 crystal Substances 0.000 description 7
- 238000000921 elemental analysis Methods 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 5
- 239000007858 starting material Substances 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 150000002170 ethers Chemical class 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 229960004592 isopropanol Drugs 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 229940117803 phenethylamine Drugs 0.000 description 3
- 238000006722 reduction reaction Methods 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 239000012259 ether extract Substances 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 150000003840 hydrochlorides Chemical class 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 229940098779 methanesulfonic acid Drugs 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- MUMZUERVLWJKNR-UHFFFAOYSA-N oxoplatinum Chemical compound [Pt]=O MUMZUERVLWJKNR-UHFFFAOYSA-N 0.000 description 2
- 229910003446 platinum oxide Inorganic materials 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 239000011369 resultant mixture Substances 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- NSMXQKNUPPXBRG-SECBINFHSA-N (R)-lisofylline Chemical group O=C1N(CCCC[C@H](O)C)C(=O)N(C)C2=C1N(C)C=N2 NSMXQKNUPPXBRG-SECBINFHSA-N 0.000 description 1
- KEQGZUUPPQEDPF-UHFFFAOYSA-N 1,3-dichloro-5,5-dimethylimidazolidine-2,4-dione Chemical compound CC1(C)N(Cl)C(=O)N(Cl)C1=O KEQGZUUPPQEDPF-UHFFFAOYSA-N 0.000 description 1
- KEFIGZIQAGNFAX-UHFFFAOYSA-N 1-(2,2-diethoxyethoxy)-2-ethoxybenzene Chemical compound CCOC(OCC)COC1=CC=CC=C1OCC KEFIGZIQAGNFAX-UHFFFAOYSA-N 0.000 description 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical compound CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 description 1
- MOEFFSWKSMRFRQ-UHFFFAOYSA-N 2-ethoxyphenol Chemical compound CCOC1=CC=CC=C1O MOEFFSWKSMRFRQ-UHFFFAOYSA-N 0.000 description 1
- BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical compound CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Natural products CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 241001135931 Anolis Species 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 239000012448 Lithium borohydride Substances 0.000 description 1
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- SPEUIVXLLWOEMJ-UHFFFAOYSA-N acetaldehyde dimethyl acetal Natural products COC(C)OC SPEUIVXLLWOEMJ-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- NMPVEAUIHMEAQP-UHFFFAOYSA-N alpha-bromo-acetaldehyde Natural products BrCC=O NMPVEAUIHMEAQP-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- RDHPKYGYEGBMSE-UHFFFAOYSA-N bromoethane Chemical compound CCBr RDHPKYGYEGBMSE-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000010531 catalytic reduction reaction Methods 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- XTHPWXDJESJLNJ-UHFFFAOYSA-N chlorosulfonic acid Substances OS(Cl)(=O)=O XTHPWXDJESJLNJ-UHFFFAOYSA-N 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 239000002024 ethyl acetate extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 150000004678 hydrides Chemical class 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 229940071870 hydroiodic acid Drugs 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 229910052987 metal hydride Inorganic materials 0.000 description 1
- 150000004681 metal hydrides Chemical class 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- YGLMBIHCBHUNBV-VIFPVBQESA-N n-[(2s)-1-(4-methoxyphenyl)propan-2-yl]acetamide Chemical compound COC1=CC=C(C[C@H](C)NC(C)=O)C=C1 YGLMBIHCBHUNBV-VIFPVBQESA-N 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- ZAEQTGTVGUJEFV-UHFFFAOYSA-N phenylmethanesulfonate;pyridin-1-ium Chemical compound C1=CC=[NH+]C=C1.[O-]S(=O)(=O)CC1=CC=CC=C1 ZAEQTGTVGUJEFV-UHFFFAOYSA-N 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000001226 reprecipitation Methods 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000000542 sulfonic acid group Chemical group 0.000 description 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 1
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
ABSTRACT OF THE DISCLOSURE
A novel process is disclosed for the production of substituted phenethylamine derivatives of the formula:
A novel process is disclosed for the production of substituted phenethylamine derivatives of the formula:
Description
311~132~
SPECIFICATION
-Title of ~he invention:
A novel process for producing substituted phenethyl-amine derivatives Detailed ex~lanation f the invention This invention relates to a process or producing a compound of the following formula (I) and a salt thereof Rl ~ C~2CIXN~CH2C 2 ~
wherein Rl represents a lower alkyl group, a lower alkoxy group, or a hyroxyl group; R2 represents a hydrogen atom, or a lower alkyl group; R3 represents a hydrogen atom or a lower alkyl group; and R4 represents a hydrogen ato~, a lower alkyl group, a lower alkoxy group, or a hydroxyl group (hereinafter, these means the same signifLcances).
U.S. Patent 4,373,106 discloses that the above formula (I) compounds exhibit ~-adrenergic bloc~ing ac~icn and are useful as an antihypertensive agent and an agent for the treatment of congestive heart failure.
So far, ~e formula (I) compounds have been produced by a process disclosed in U.S. Patent No. 4,217,305 or ~,373~ 106. This prior art process is as follows:
;~
~ \
SPECIFICATION
-Title of ~he invention:
A novel process for producing substituted phenethyl-amine derivatives Detailed ex~lanation f the invention This invention relates to a process or producing a compound of the following formula (I) and a salt thereof Rl ~ C~2CIXN~CH2C 2 ~
wherein Rl represents a lower alkyl group, a lower alkoxy group, or a hyroxyl group; R2 represents a hydrogen atom, or a lower alkyl group; R3 represents a hydrogen atom or a lower alkyl group; and R4 represents a hydrogen ato~, a lower alkyl group, a lower alkoxy group, or a hydroxyl group (hereinafter, these means the same signifLcances).
U.S. Patent 4,373,106 discloses that the above formula (I) compounds exhibit ~-adrenergic bloc~ing ac~icn and are useful as an antihypertensive agent and an agent for the treatment of congestive heart failure.
So far, ~e formula (I) compounds have been produced by a process disclosed in U.S. Patent No. 4,217,305 or ~,373~ 106. This prior art process is as follows:
;~
~ \
2~
SO~NH~ . SO~NH ~3 0 R~ 4 or R ~3 CH--CH ¦
o~q R2 ( b ) 5~Z
1 H~NCH2 C~ O--~ U . S . Pat . 4 ,217,305 So~NH R3 Rl ~CEI CEINH CH7 CH~0 ~ _ o~R2 R~
ogenation S07~
.s~ P~. 4j373,106 R~ CH~ ICEzCE~0 R2 R~
.1, Reduction ( I ) - - (I~ the above formulae, A represe~ts a halogen atom, and Rl, R2, R3 and R4 are as defined above. ) An object of the invention of this applica,ion is to provide a novel process for producing the formula (I) compounds which process is easy and suitable for industrial production of the compounds (I).
... . ,--. - - ~
~%~
That is, this invention relates to a process for producing a compound of the formula (I) or a salt therof which comprises reacting a compound of the formula R~ CH CXN / 1 (II) (wherein Rl, R2, and R3 are as defined above; and Xl and X2 represent a hydrogen atom or a protective group for an amino group) or a salt thereof with a sub~tituted phenoxy compound ~- ~ 2 (III) .
~wherein R4 is as defined above; and Y represents an aldehyde gr~p which may be protected, or -CH2-Z- (Z
represents a remov ~g group)~ and then, if Y is an aldehyde group which may be pro~ected, reducing the for~ed compound.
The compounds (I) contain an asymmetric carbon atom if R2 is a lower-alkyl group, and the aimed co~pounds (I) of the process of this invention include the racemic compounds thereof, a mixture of the racemic compounds .and each optically active substance . Each optically active substance or the recemic co~pounds o~ the compo~ds (I) can be produced by using an optically active or : racemic compound of- the s~arting material (II~
SO~NH~ . SO~NH ~3 0 R~ 4 or R ~3 CH--CH ¦
o~q R2 ( b ) 5~Z
1 H~NCH2 C~ O--~ U . S . Pat . 4 ,217,305 So~NH R3 Rl ~CEI CEINH CH7 CH~0 ~ _ o~R2 R~
ogenation S07~
.s~ P~. 4j373,106 R~ CH~ ICEzCE~0 R2 R~
.1, Reduction ( I ) - - (I~ the above formulae, A represe~ts a halogen atom, and Rl, R2, R3 and R4 are as defined above. ) An object of the invention of this applica,ion is to provide a novel process for producing the formula (I) compounds which process is easy and suitable for industrial production of the compounds (I).
... . ,--. - - ~
~%~
That is, this invention relates to a process for producing a compound of the formula (I) or a salt therof which comprises reacting a compound of the formula R~ CH CXN / 1 (II) (wherein Rl, R2, and R3 are as defined above; and Xl and X2 represent a hydrogen atom or a protective group for an amino group) or a salt thereof with a sub~tituted phenoxy compound ~- ~ 2 (III) .
~wherein R4 is as defined above; and Y represents an aldehyde gr~p which may be protected, or -CH2-Z- (Z
represents a remov ~g group)~ and then, if Y is an aldehyde group which may be pro~ected, reducing the for~ed compound.
The compounds (I) contain an asymmetric carbon atom if R2 is a lower-alkyl group, and the aimed co~pounds (I) of the process of this invention include the racemic compounds thereof, a mixture of the racemic compounds .and each optically active substance . Each optically active substance or the recemic co~pounds o~ the compo~ds (I) can be produced by using an optically active or : racemic compound of- the s~arting material (II~
3-- .
.
~2~2~1~7 The term "lower" used in the above forumla means a straight or branched chain having 1 to 5 carbon atoms.
Therefore, for example, a lower alkyl group includes methyl grcup, ethyl group, propyl group, butyl group, pen~yl group, isobutyl group, etc., anda lower alkoxy group includes methoxy group, ethoxy group, propoxy group, bu~oxy group, etc. The term l'halogen" in ~he formula means chlorine, bromine, iodine or fluorine.
As a protec~ive group for ~n amino group for Xl or X2, there are, or ~e~ple, trityl, substituted-trityl, kenzyl, substituted-t~ityl, benzyl, substit ~ d-benzyl, benzvlo~y~e~T~l, subs~tuted ~ nzyloxy, t~ethylsilyl, metho~thyl, etc.; as a prote ~ ve grouD fo~ an_loehydeE group for Y, there are, ~or e~Dle, dia~laoetals (e.g., ~ lacetale, diethylaoet21e, etc.), ring stn~lre aoet~les (e.g., et~leneaoetale, etc.), acylales (e.g., diaoetvl, etc.), which pn~ctive groups do not af~ect ~ reacticns and can be easily r;eleased. As a re~ovin~
gxoup which Z m~, there are, for ~le, a h310sen atom, or an or~c sulfonic acid residue such as tosvl, neth ~ sulfonyl, The compounds (I) or the starting compounds (II) can orm salts thereofte g. a salt with an inor~c add 5uch as hydrochloric acid, hydrobromic acid, hydroiodic acid, sulfuric acid, nitric acid or phosphoric acid, or with an organic acid such as formic acid, acetic acid, citric acid, succinic acid, fumaric acid, maleic acid/ tartaric acid, methanesulfonic acid, ethanesuIfonic acid, etc. These salts can be produced by an ordinary manner for producing such salts.
- ~2~32~
The processes of the invention are further described in more detail.
Firs~ly, a phenethylamine compound ~) or its salt is reacted with an reactive equivalent amount of a substituted phenoxy compound (III) in an organic sol~ent suitable for the reaction (Process I), and then, if Y is an aldehyde group which may be protected, the formed compound is subjected to a reducing reaction (Process II).
These processes are schematically shown below.
S02N~IR3 Rl~_C~ CHN/ + ~OC~I Y
212\x2 \j=( 2 tor its salt) R R4 (III) (II) _ ~
- Process I Process II
( in the case o f Y being an aldehyde - group whi ch may be prote cted ) . R~ 3cx2c~N=cxcx2o~
r ~ (V) reduction Rl--~ \~CH2fl~N~C~2 2 R .4 (I) R
~2~2~
Process I
This process ~that is, the reaction of a phenethylamine compound (II) or its salt with a substituted phenoxy compound (III)) can be performed in a solvent (which is inert to the reaction) such as alcohols(e.g.,me~ol, ethanol, iso-proDanol,etc.) ethers(e.g.,dioxane,tetrahydrofura~, acetonitrile, dimethyl-formamide, dimethylsulfoxide, etc. ~n equimolar or excess amount of the o~ounds is usedfor the reactIon.
It may be preferred to use an equimolar amou~t of Compounds if there eY~ist inorganic base (for example, potassium carbona~e, sodium carbonete, sodium hydrogen carbonate, etc.) or an organic ~ase (for example, triethylamine~ pyridine, picoline, N,N-dimethylaniline, N-methylmorpholine, etc.).
In the case of the o~ound (II) ~eing used, it may be preferred to perform the rea~icns in the preseneoe of an inorganic or orqanic base~
The reaction temperature or time may be changed suitably, considering the kind of Compound (II) or (III), or of sol-~ent.
The reaction is preferably performed in usual at room temperature or under heating such as under reflux.
Process II
.
The reactioll of a phenethylamine compound (II) or its salt with a substituted phenoxy compound in case of Y being an aldehyde group which may be protected,is usuallv ~rfo ~ d in a sol~ent which is inert to the reaction and can solubilize the reaction oom-pounds (e.g., alcohols such as methanol, eth2nol, iso-pro~anoli ethers such as tetrahydrofuran, dioxanei acetonitrile, d ~ thyl-fon~de, diemthylsulfo~lde~ at ~x~ tem¢erature or un~er heating.
, .
. .
''-''' The reaction can be finished in about 1 hour. The formed compound (IV) (in the reaction solution or after isolating) is then reduced. In this process, an acetal compound may be used instead of the formula (III) compound (in this case, the acetal compound is firstly hydroly~ed by using an inorganic acid (e.g., hydrochloric acid) t an organic acid (e.g., acetic acid, formic acid, toluenesulfonic acid, methanesulfonic acid), an organic acid salt (e.g., pyridine-toluenesulfonic acid salt), etc., and then, is subjected to the following reaction). The reduction can be accomplished in alcohols (e.g., methanol, ethanol, iso-propanol) or ethers (e.g., dioxane, tetrahydrofuran by adopting catalytic reduction using platinum oxide, palladium catalyst, Baney nickel,* or by using metal hydride such as sodium borvhydride, sodium borocyanohydride, lithium borohydride, lithium alminum hydride, etc.
*Trade Mark . ' .
1 32~
The desired compounds of this invention thus prepared is obtaiRed as free base or its salt. The free ~ase compound may be subjected to a salt forming reaction by a usual method,and the salt may be isolated and ourified by usual ma.~ner.The isolation and purification of the compounds can be ac~omplished by usual chemical procedures ~uch as filtratior~, extraction, recrystalli-zation, reprecipitation, various chromatagraphies, etc.
(Effects of the invention) In the case of the prior art methods for producing the compounds of this invention, there are needed ~anv steps of reaction, and so there is a difficulty in ~ ~rior art __ _ _ methods- for its mdustri~l ap~lication. In the case or ~ s invention, there is ne~ded on_~ an ext~_y fewer steps than the prior art methods,sincethe reaction procedures are simple; and the deslred compounds can be obtained in high yield. Accordingly, the method or this invention is very suitable for the industrial aDp~cation.
Purther, the reac~ns of this invention never accompany racemisation. Hence, each optical i:~rof the formula (I) com~ound Qn ~eselectively produced by using ~orresponding optical isomer of the starting material ~II) which is ' , . . '' ' . ~ '' :
' ~.
easily produced.
In order to explain the invention in more detail, there are set out below Reference Examples and Examples.
The formula (III) compounds which are starting materials for the processes of this invention, are novel compounds, and Reference Examples below show the production thereof.
Further, optical isomers of the phenethylamine derivatives of the formul~ (II) and their production are shown in Reference Examples 2 and 3.
Reference Example 1 Sodium hy~ri~e-(-in oil,-60%;--4.6g) was stirred in dry diemthylformami~e (100 ml), and after adding ~.~owly there-to 13.8 g of o-ethoxyphenol ,'the resultant mixture was x O
stirred under heatin~ at 60 C for l hour~ Then, under ice-cooling, 19.7 g of bromoacetaldehyde diethyl ac~tal ~was added drop~ise to the reaction mixture over a period of 1 hour. The reaction mixture was stirred at room temperature overnight, was heated while tirring at 60 C
for 2 hours, and then was poured into 500 ml of ice-water.
After extracting with ethyl acetate, the extract was wa~hed with water, and dryed over anhydrous sodium sulfate.
The solvents were distilled away to give oily residu~. The residue was distilled under reduced pressure to give oily material of 2-(0-ethoxyphenoxy)acetaldehyde diethyl acetal (12 g).
Boiling point: 113-116 C (0.5 mmHg) . .. ..... --q_ .... .. . .. .. . . .. . .. .
. . . . . - . .
'; ~' ' ., -P-N~IR ( CDCl3) o: 1.2~L ( 6~I, t, J=
~z, -CE7 C~I3 X 2 ), 1.~ 2 ( 3E? tr J=~Ez, -~E~
CH3), 3.4~ 3.9 ( 4H~ ~.. -OC~z CH3 X 2 ), 3.C~ 402 ( ~lF~, m, -OCl~I7 C~:3~ ~OCE7 C~ < ), A.8 6 ( l H, t, J=
5~z, -OCH7 CE< ), 6.8 8 (4E, s, aromatic ring) Referenoe Exam~le 2 (Prepara~ion of R(-) ~ound) a) In 6 ml of pyridine was dissol.ved 1.5 ~ ofR(-~-2-~p-methoxyphenyl)-l-methylethylamlne ( ~ ~23:-30.1 (c-1..2,--ne-~ha~ol)j~--arld after-addin~ there o 3 ml of .._ .. ..._ ... . _ .. . . . .
acetic cnhydride, the mix.ure was allowea to stand at~
room tem~e~ature for 1 hour. After distilling o~~ the solvent, the residue ~as extrzcted with e~:~yl acet~te:
The ethyl acetate ex,rac, was washed with water, ana dried over annYarous sodium sulrate,ancthesolvent as aistilled orf 2nd the c_ude c,vstals formed were recrys .cllized from z mi:~ture or n-hexane and ~enzene to provide 1.8 g of (R)(.)-~-acetyl-2-(p-me_hoxv?renYl)-l-methyle '~hylamine.
elting point: 92-93C
~ic-.-entcl anaivsis ~or C12~17~-02:
C(%) H~%) N(~) C~lc! ~ . 69.54 8.27 6.76 Found: 69 41 8.19 6 66 ]24:1~.8 (c=l.O9, methanol) ....
. - - ,~- , , " .
b) In 60 g of chlorosulfonic acid was added 6 g of (R) (T)-N-acetyl-2-~p-methoxyphenyl)-1-methylethylamine, under cooling at 0 to -10C. The mixture was stirred for 1 hour at 0 to 5C, and the reaction solution was poured into 600 g of ice-water. The oily material precipitated was extracted with ethyl acetate, and the ethyl acetate extract was washed by a saturated aqueous sodium hydrogen carbonate solution and dried over anhydrous sodium sulfate. After distilling off the solvent, the formed residue (without purification) was dissolved in 120 ml of tetrahydrofuran.
After adding dropwise thereto 180 ml of a concentrated aqueous ammonia solution, the mixture was stirred for 1 hour at room temperature. The crystals precipitated were collected by filtration, washed with water, and recrystallized from methanol to provide 6 g of (R)~ N-acetyl-5-[(2-amino-2-methyl)-ethyl]-2-methoxybenzenesulfonamide; another name: R(~)-5-~2-acetylamino)propyl]-2-methoxybenzenesulfonamide.
Melting point: 197-198C
Elemental analysis for C12H18N2O4S:
(C%) H~%~ N(%) Calcd.: 50.34 6.34 9.78 Found: 50.28 6.41 9.69 ~]24:14.7 (c=1.0, methanol) ac~9 ~ O ~
c) 5 g of (Rj (I)-N-acetyl 5-[(2-amino-2-methyl)ethyl]-2-methoxybenzenesulfonamide was dissol~ed in 125 ml of 5%
hydrochloric acid, and the solution was refluxed under heating for 16 hours. After distilling off the solvent, the crude crystals formed were recrystallized from isopropanol to provide 4.5 g of (R) (-)-5-[(2-amino-2-methyl)ethyl]-2-methoxybenzenesulfonamide; namely, R(-~-5-(2-aminopropyl) 2-methoxybenzenesulfonamide (HCl salt).
Melting point: 273-277 C (decomposition) Elemental analysis for C10H17C1N2O3S:
C(%) H(%) N(%) Calcd.: 42.78 6.10 9.98 Found: 42.68 6.00 9.93 [a]24: -6.3~ (c=1.03, methanol) D
Reference Example 3 (Preparation of S(+) compound) a) By following the same procedure as in Reference Example 2(a), (S) (-)-N-acetyl-2-(p-methoxyphenyl)-1-methylethylamine was obtained by using S(~)-2-(p-methoxyphenyl)-1-methylethylamine.
Melting point: 94-96C
Elemental analysis for C12H17N2:
C(%) H(%) N(~) Calcd........ 69.54 8.27 6.76 Found: 69.~7 8.31 6.69 [a]2~: -15.3 (c=1.25, methanol) ~82~7~
b) ~y following the same procedure as in Reference Example 2(b), (S)(-)-N-acetyl-5-[(2-2mino-Z-methyl)-ethyl]-2-methoxybenzenesulonamide ~another name:
5(-)-5-[2-(acetylan.ino)propyl]-2-methoxybenzene-sulfonamide)was obtained by using ~S)(-)-N-acetyl-2-(p-methoxyphenyl)-1-methylethYlamine as the starting material.
Melting point: 196-198C
Ysls ~or C12X18N20 S
C(%) ~(%) N(%) Calcd.: 50.34 6.34 9.78 Found: 50.31- 6.24 9~73 ~]D -:-14.2 (c=l.01, me_;~anol) c) By following the same procedure as in Reference Ex.
2(c), (S) (T) -5-[(2-amino-2-methyl)ethyl]-2-methoxybenzene-sulfonamide was obtained by using (S)(-)-N-acetyl-5-[(2-amino-2-methyl)ethyl]-2-methoxybenzenesulfonamide as the starting material.
Melting point: 273-276C (decomposition Elemental analysis for ClOH17~lN2O3S:
C(%) H(%) N(%) Calcd.: 42.78 6.10 9.98 Found: 42.65 6.03 9.89 [~]24: 6.0 (c=l.01, methanol) '~ .
3LZ8Zq:~7 Example 1 2.8 g of 2-(o-ethoxyphenoxy)acetaldehyde diethyl acetal was dissolved in 20 ml of acet~ne, and after adding thereto 3 ml of 6N-hydrochloric acid, the mixture was stirred~for 1.5 hour at room temperature.
The solvent was distiled away and after adding water~to the residue, the precipitated oily material was extracted with ether. The ether extract was washed with water, and dried over anhydrous sodium sulfate. The solvent was distilled away to give oily residue. The residue was dissolved in 100 ml of methanol and fter adding ~~~ theretb R~ 5-(2-aminopropyl)-2-methoxybenzensulfonamide (2.4 g~, the mixture was refluxed under heating for 1 hour. After coo~ing, 0.25 g of platinum oxide catalyst was added, and the reaction mixtuxe was subjected ~o re~uction reaction by a usual manner. The catalyst was remove~ by filtration and after acidifying the filtxate with ~Cl-ethanol, the solvent was distilled away. The residue was recrystallized from methanol to give R(-)-5~[2-[[2-(o-ethoxyphenoxy)ethyl]amino]propyl]-2-methoxybenzensulfonamide ~Cl salt.
Melting point 228-230 C [~¦D -4.1 (methanol) 5~
:~
', Example 2 ~ y following the same procédure as in Example 1, by using S(+)-5-(2-aminopropyl-2-methoxybenzenesulfon-amide (instead of R(-)-5-(2waminopropyl)-2-methoxy benzenesulfonamide), 5(+)-5-[2-[~2-(o-ethoxyphenoxy)-ethyl]amino]propyl]-2-methcxybenze~esulfonamide HCl salt.
Melting point: 228-230C ~]24 +4 1 ~methanol) Example 3 By following the same procedure as in Example 1, by using racemic compound of 5-(2-aminopropyl)-2-methoxy-benzenesulfonamide (instead of R(-)-5-(2-aminopropyl)-2-methoxybenzenesulfon~lide), racemic compound of 5-[2-[[2-(o-ethoxyphenoxy)ethyl]amino]propyi]-2-methoxybenzene-sulfonamide RCl salt.
Melting point: 254-256~C
Examp~le 4 2.8 g of 2-(o ethoxyphenoxy)acetaldehyde diethyl acstal was dissolved in 20 ml of acetone, and after adding thereto 3 ml of 6N-hydrochloric acid, the resultant mixture was stirred at room temperature for 1.5 hour. The solvent was distilled away, and after adding water to the residue, the precipitated oily material was extracted with ether. The ether extract was washed with water, and dried over anhydrous sodium sulfate. The solvent was distiled awav to give oily residue. The residue was dissolved in 10~ ml of me~hanol and after adding thereto 2.4 g of R(~ (2-aminopropyl)-~'~8~
-2-methoxybenzenesulfonamide, the mixture was refluxed under heating for 1 hour. Then, sodium borohydride (0.42 g) was added to the mixture at 5-10C over a period of 1 hour, the mixture was allowed to stand overnight. The solvent ~as distilled away, and the residue was extracted with ethyl acetate. The extract was washed with water, and dried over anhydrous sodium sulfate. The solvent was distilled away, a~d the residue was treated with HC1-ethanol, and recrystallized from methanol to give R(-)-5-[2-[[2-(o-ethoxyphenoxy)ethyl]amino]propyl]-2-methoxybenzenesulfonamide HC1 salt.
Melting point: 228 230 C
[~]24 +4.1 tmethanol) D
Example 5 By following the same procedure as in Example 4, by using S(~)-5-(2-aminopropyl)-2-methoxybenzenesulfonamide (instead of R(-)-5-(2-aminopropyl)-2-methoxybenzene-sulfonamide), S(~)-5-[2-[[2-(o-ethoxyphenoxy)-ethyl]propyl]-2-methoxybenzenesulfonamide HC1 salt.
Melting point: 228 230C
[~]24 ~g.l (methanol) D
Example 6 By following the same procedure as in Example 4, by using racemic compound of 5 (2-aminopropyl)-2-methoxy-benzenesulfonamide (instead of R(-)-5-(2-aminopropyl)-2-methoxybenzenesulfonamide), racemic compound of 5-[2-[~2-~o-ethoxyphenoxy)ethyl]propyl]-2-methoxybenzene-sulfonamide HC1 salt. Melting point: i55_156 C.
Example 7 In 120 ml of ethanol were dissolved 2.4 g of (R)(-)~5-(2-aminopropyl)-2-methoxybenzenesulfonamide and 1.2 g of 2-~o-ethoxyphenoxy)ethyl bromide, and the mixture was refluxed for 16 hours under heating. The solvent was distilled away, and after alkalifing the residue by the addition of 10% sodium hydroxide, and the oily material precipitated was extraced with ethyl acetate. The extract solution was washed with a saturated aqueous sodium chloride, and dried over anhydrous magnesium sulfate. The solvent was distilled away, and the residue was subjected to column chromatography. The product was eluted with CHC13-methanol (9 5) to provide 1.5 g of the crude crystals of (R)(-)-5-[2-~[2-(o-ethoxyphenoxy)-ethyl]amino]-2-methylethyl]-2-methoxybenzenesulfonamide, which was treated with HC1-ethanol to give a hydrochloric acid salt of (R) ~ 5-[2-[[2-(o-ethoxyphenoxy)ethyl]-amino]propyl]-2-methoxybenzenesulfonamide.
Melting point: 228-230C
Elemental analysis for C~oH2gClN2OsS:
C~%) H(%) N(%) Calcd.: 53.99 6.57 6.30 Found: 53.90 6.64 6.27 [a]24: -4.0 (c=0.35, methanol) ~2~
Exzmple 8 By followina the same proced~re Jas in ExamDle 7 (S)( )-5-[2-[~2-(o-ethoxvphenoxv)ethvl]amino]-propyl]-2-methXyDenzenesulfcnamide HC1 salt was obtained by using (S)( )-5-[(2-aminopropyl) -- 2-methoxy-benzenesulfon2mide as the star~inc mzt~zl.
~elting point: 228-230C (met~anol~
Element~l analysis ~or C20-~29ClN2O5S:
C(~) H(%) N(~) Cacld.: 53.~9 6.57 6.30 Faund: 5:3-g2 6.57 6.~5 [~ 24 4 2 (c=0.36, methanol~
~ l 9 _ : --, .
137~
Example 9 3 ~ ~2CH HCH2CH2o ~
HCl 1) In 40 ml of water was dissolved R(-)-5-(2-amino-propyl)-2-methoxybenzenesulfonamide HCl salt (4 g) by heating, and after adding thereto 14 ml of a saturated aqueous potassium carbonate solution, the mixture was stirred at 5C for 2 hours. The precipitated crystals were collected by filtration,-and the crystals obtained weré recrystallized from ethanol to give 2.6 g of R(-~-5~(2-aminopropyl)-2-methaxybenzenesulfonamide.
Melting point: 166-167C
[~ ~23 -17.3 (c=1.07, methanol) 2) In 5 ml of N,N-dimelthylformamide were dissolved 976 mg of R(-)-5-(2-aminopropyl)-2-methoxybenzenesulfon-amide and 245 mg of 2-(o-ethoxyphenoxy)ethyl ~romide, and after heating the solution at 60C for 5-7 hours, the solvent was distilled away. To the residue was add-ed 28 ml of water, and the mixture was refluxed under heating for 30 minutes. The mixture was stirred at 5C for 1 hour, and the crystals precipita~ed during .he stirring were collected by filtration. The crystals collected were recrystalized from iso propanol to give 320 mg of R(~ [2-[[2-(o-ethoxyphenoxy)ethyl]amino]-: ;~. . _ .
, 32~7~7 propyl]-2-methoxybenzenesulfonamide. This product was dissolved in 9.6 ml of methanol while heati~g, and after acidifying the solution by addition of conc.
hydrochloric acid under heating, the mixture was stirred at 5C overnight. The orystals precipitated were collected by flltration to give 270 mg of R(-)-5-[2-1~2-(o-ethoxyphenoxy)ethyl]amino~propyl]-2-methoxybenzenesulfonamide HC1 salt.
Melting point: 227-230C
Elemental analysis for C20H29clN2o5s C(~ H~) N(~
Cacld. 53.98 6.57 6.30 Found: 54.01 6.35 6.27 [~ ]22 _4,~o (c=0.35, methanol) Example 10 S02N~I2 CH30~EI2CHNHCH2CH20 c~3 C2H5 HCl 3y following the same procedure as in Example 9, by using the corresponding S(~)-isomer instead of R(-)-5-(2-aminopropyl)-2-methoxybenzenesulfonamide, S(~)-5-[2-[[2-(o-ethoxyphenoxy)ethyl]amino~propyl]-2-methoxybenzenesulfonamide HCl salt was obtained.
Melting point: 228-230C
,, , , _ ~2~
Elemental analysis for C~0~29ClN205S
C(~) H(~) N(%) Cacld.: 53.98 6.57 6.30 Found: 53 90 6.55 6.29 [~]234.2 (c=0.36, methanol) --2~--. .
.
.
.
~2~2~1~7 The term "lower" used in the above forumla means a straight or branched chain having 1 to 5 carbon atoms.
Therefore, for example, a lower alkyl group includes methyl grcup, ethyl group, propyl group, butyl group, pen~yl group, isobutyl group, etc., anda lower alkoxy group includes methoxy group, ethoxy group, propoxy group, bu~oxy group, etc. The term l'halogen" in ~he formula means chlorine, bromine, iodine or fluorine.
As a protec~ive group for ~n amino group for Xl or X2, there are, or ~e~ple, trityl, substituted-trityl, kenzyl, substituted-t~ityl, benzyl, substit ~ d-benzyl, benzvlo~y~e~T~l, subs~tuted ~ nzyloxy, t~ethylsilyl, metho~thyl, etc.; as a prote ~ ve grouD fo~ an_loehydeE group for Y, there are, ~or e~Dle, dia~laoetals (e.g., ~ lacetale, diethylaoet21e, etc.), ring stn~lre aoet~les (e.g., et~leneaoetale, etc.), acylales (e.g., diaoetvl, etc.), which pn~ctive groups do not af~ect ~ reacticns and can be easily r;eleased. As a re~ovin~
gxoup which Z m~, there are, for ~le, a h310sen atom, or an or~c sulfonic acid residue such as tosvl, neth ~ sulfonyl, The compounds (I) or the starting compounds (II) can orm salts thereofte g. a salt with an inor~c add 5uch as hydrochloric acid, hydrobromic acid, hydroiodic acid, sulfuric acid, nitric acid or phosphoric acid, or with an organic acid such as formic acid, acetic acid, citric acid, succinic acid, fumaric acid, maleic acid/ tartaric acid, methanesulfonic acid, ethanesuIfonic acid, etc. These salts can be produced by an ordinary manner for producing such salts.
- ~2~32~
The processes of the invention are further described in more detail.
Firs~ly, a phenethylamine compound ~) or its salt is reacted with an reactive equivalent amount of a substituted phenoxy compound (III) in an organic sol~ent suitable for the reaction (Process I), and then, if Y is an aldehyde group which may be protected, the formed compound is subjected to a reducing reaction (Process II).
These processes are schematically shown below.
S02N~IR3 Rl~_C~ CHN/ + ~OC~I Y
212\x2 \j=( 2 tor its salt) R R4 (III) (II) _ ~
- Process I Process II
( in the case o f Y being an aldehyde - group whi ch may be prote cted ) . R~ 3cx2c~N=cxcx2o~
r ~ (V) reduction Rl--~ \~CH2fl~N~C~2 2 R .4 (I) R
~2~2~
Process I
This process ~that is, the reaction of a phenethylamine compound (II) or its salt with a substituted phenoxy compound (III)) can be performed in a solvent (which is inert to the reaction) such as alcohols(e.g.,me~ol, ethanol, iso-proDanol,etc.) ethers(e.g.,dioxane,tetrahydrofura~, acetonitrile, dimethyl-formamide, dimethylsulfoxide, etc. ~n equimolar or excess amount of the o~ounds is usedfor the reactIon.
It may be preferred to use an equimolar amou~t of Compounds if there eY~ist inorganic base (for example, potassium carbona~e, sodium carbonete, sodium hydrogen carbonate, etc.) or an organic ~ase (for example, triethylamine~ pyridine, picoline, N,N-dimethylaniline, N-methylmorpholine, etc.).
In the case of the o~ound (II) ~eing used, it may be preferred to perform the rea~icns in the preseneoe of an inorganic or orqanic base~
The reaction temperature or time may be changed suitably, considering the kind of Compound (II) or (III), or of sol-~ent.
The reaction is preferably performed in usual at room temperature or under heating such as under reflux.
Process II
.
The reactioll of a phenethylamine compound (II) or its salt with a substituted phenoxy compound in case of Y being an aldehyde group which may be protected,is usuallv ~rfo ~ d in a sol~ent which is inert to the reaction and can solubilize the reaction oom-pounds (e.g., alcohols such as methanol, eth2nol, iso-pro~anoli ethers such as tetrahydrofuran, dioxanei acetonitrile, d ~ thyl-fon~de, diemthylsulfo~lde~ at ~x~ tem¢erature or un~er heating.
, .
. .
''-''' The reaction can be finished in about 1 hour. The formed compound (IV) (in the reaction solution or after isolating) is then reduced. In this process, an acetal compound may be used instead of the formula (III) compound (in this case, the acetal compound is firstly hydroly~ed by using an inorganic acid (e.g., hydrochloric acid) t an organic acid (e.g., acetic acid, formic acid, toluenesulfonic acid, methanesulfonic acid), an organic acid salt (e.g., pyridine-toluenesulfonic acid salt), etc., and then, is subjected to the following reaction). The reduction can be accomplished in alcohols (e.g., methanol, ethanol, iso-propanol) or ethers (e.g., dioxane, tetrahydrofuran by adopting catalytic reduction using platinum oxide, palladium catalyst, Baney nickel,* or by using metal hydride such as sodium borvhydride, sodium borocyanohydride, lithium borohydride, lithium alminum hydride, etc.
*Trade Mark . ' .
1 32~
The desired compounds of this invention thus prepared is obtaiRed as free base or its salt. The free ~ase compound may be subjected to a salt forming reaction by a usual method,and the salt may be isolated and ourified by usual ma.~ner.The isolation and purification of the compounds can be ac~omplished by usual chemical procedures ~uch as filtratior~, extraction, recrystalli-zation, reprecipitation, various chromatagraphies, etc.
(Effects of the invention) In the case of the prior art methods for producing the compounds of this invention, there are needed ~anv steps of reaction, and so there is a difficulty in ~ ~rior art __ _ _ methods- for its mdustri~l ap~lication. In the case or ~ s invention, there is ne~ded on_~ an ext~_y fewer steps than the prior art methods,sincethe reaction procedures are simple; and the deslred compounds can be obtained in high yield. Accordingly, the method or this invention is very suitable for the industrial aDp~cation.
Purther, the reac~ns of this invention never accompany racemisation. Hence, each optical i:~rof the formula (I) com~ound Qn ~eselectively produced by using ~orresponding optical isomer of the starting material ~II) which is ' , . . '' ' . ~ '' :
' ~.
easily produced.
In order to explain the invention in more detail, there are set out below Reference Examples and Examples.
The formula (III) compounds which are starting materials for the processes of this invention, are novel compounds, and Reference Examples below show the production thereof.
Further, optical isomers of the phenethylamine derivatives of the formul~ (II) and their production are shown in Reference Examples 2 and 3.
Reference Example 1 Sodium hy~ri~e-(-in oil,-60%;--4.6g) was stirred in dry diemthylformami~e (100 ml), and after adding ~.~owly there-to 13.8 g of o-ethoxyphenol ,'the resultant mixture was x O
stirred under heatin~ at 60 C for l hour~ Then, under ice-cooling, 19.7 g of bromoacetaldehyde diethyl ac~tal ~was added drop~ise to the reaction mixture over a period of 1 hour. The reaction mixture was stirred at room temperature overnight, was heated while tirring at 60 C
for 2 hours, and then was poured into 500 ml of ice-water.
After extracting with ethyl acetate, the extract was wa~hed with water, and dryed over anhydrous sodium sulfate.
The solvents were distilled away to give oily residu~. The residue was distilled under reduced pressure to give oily material of 2-(0-ethoxyphenoxy)acetaldehyde diethyl acetal (12 g).
Boiling point: 113-116 C (0.5 mmHg) . .. ..... --q_ .... .. . .. .. . . .. . .. .
. . . . . - . .
'; ~' ' ., -P-N~IR ( CDCl3) o: 1.2~L ( 6~I, t, J=
~z, -CE7 C~I3 X 2 ), 1.~ 2 ( 3E? tr J=~Ez, -~E~
CH3), 3.4~ 3.9 ( 4H~ ~.. -OC~z CH3 X 2 ), 3.C~ 402 ( ~lF~, m, -OCl~I7 C~:3~ ~OCE7 C~ < ), A.8 6 ( l H, t, J=
5~z, -OCH7 CE< ), 6.8 8 (4E, s, aromatic ring) Referenoe Exam~le 2 (Prepara~ion of R(-) ~ound) a) In 6 ml of pyridine was dissol.ved 1.5 ~ ofR(-~-2-~p-methoxyphenyl)-l-methylethylamlne ( ~ ~23:-30.1 (c-1..2,--ne-~ha~ol)j~--arld after-addin~ there o 3 ml of .._ .. ..._ ... . _ .. . . . .
acetic cnhydride, the mix.ure was allowea to stand at~
room tem~e~ature for 1 hour. After distilling o~~ the solvent, the residue ~as extrzcted with e~:~yl acet~te:
The ethyl acetate ex,rac, was washed with water, ana dried over annYarous sodium sulrate,ancthesolvent as aistilled orf 2nd the c_ude c,vstals formed were recrys .cllized from z mi:~ture or n-hexane and ~enzene to provide 1.8 g of (R)(.)-~-acetyl-2-(p-me_hoxv?renYl)-l-methyle '~hylamine.
elting point: 92-93C
~ic-.-entcl anaivsis ~or C12~17~-02:
C(%) H~%) N(~) C~lc! ~ . 69.54 8.27 6.76 Found: 69 41 8.19 6 66 ]24:1~.8 (c=l.O9, methanol) ....
. - - ,~- , , " .
b) In 60 g of chlorosulfonic acid was added 6 g of (R) (T)-N-acetyl-2-~p-methoxyphenyl)-1-methylethylamine, under cooling at 0 to -10C. The mixture was stirred for 1 hour at 0 to 5C, and the reaction solution was poured into 600 g of ice-water. The oily material precipitated was extracted with ethyl acetate, and the ethyl acetate extract was washed by a saturated aqueous sodium hydrogen carbonate solution and dried over anhydrous sodium sulfate. After distilling off the solvent, the formed residue (without purification) was dissolved in 120 ml of tetrahydrofuran.
After adding dropwise thereto 180 ml of a concentrated aqueous ammonia solution, the mixture was stirred for 1 hour at room temperature. The crystals precipitated were collected by filtration, washed with water, and recrystallized from methanol to provide 6 g of (R)~ N-acetyl-5-[(2-amino-2-methyl)-ethyl]-2-methoxybenzenesulfonamide; another name: R(~)-5-~2-acetylamino)propyl]-2-methoxybenzenesulfonamide.
Melting point: 197-198C
Elemental analysis for C12H18N2O4S:
(C%) H~%~ N(%) Calcd.: 50.34 6.34 9.78 Found: 50.28 6.41 9.69 ~]24:14.7 (c=1.0, methanol) ac~9 ~ O ~
c) 5 g of (Rj (I)-N-acetyl 5-[(2-amino-2-methyl)ethyl]-2-methoxybenzenesulfonamide was dissol~ed in 125 ml of 5%
hydrochloric acid, and the solution was refluxed under heating for 16 hours. After distilling off the solvent, the crude crystals formed were recrystallized from isopropanol to provide 4.5 g of (R) (-)-5-[(2-amino-2-methyl)ethyl]-2-methoxybenzenesulfonamide; namely, R(-~-5-(2-aminopropyl) 2-methoxybenzenesulfonamide (HCl salt).
Melting point: 273-277 C (decomposition) Elemental analysis for C10H17C1N2O3S:
C(%) H(%) N(%) Calcd.: 42.78 6.10 9.98 Found: 42.68 6.00 9.93 [a]24: -6.3~ (c=1.03, methanol) D
Reference Example 3 (Preparation of S(+) compound) a) By following the same procedure as in Reference Example 2(a), (S) (-)-N-acetyl-2-(p-methoxyphenyl)-1-methylethylamine was obtained by using S(~)-2-(p-methoxyphenyl)-1-methylethylamine.
Melting point: 94-96C
Elemental analysis for C12H17N2:
C(%) H(%) N(~) Calcd........ 69.54 8.27 6.76 Found: 69.~7 8.31 6.69 [a]2~: -15.3 (c=1.25, methanol) ~82~7~
b) ~y following the same procedure as in Reference Example 2(b), (S)(-)-N-acetyl-5-[(2-2mino-Z-methyl)-ethyl]-2-methoxybenzenesulonamide ~another name:
5(-)-5-[2-(acetylan.ino)propyl]-2-methoxybenzene-sulfonamide)was obtained by using ~S)(-)-N-acetyl-2-(p-methoxyphenyl)-1-methylethYlamine as the starting material.
Melting point: 196-198C
Ysls ~or C12X18N20 S
C(%) ~(%) N(%) Calcd.: 50.34 6.34 9.78 Found: 50.31- 6.24 9~73 ~]D -:-14.2 (c=l.01, me_;~anol) c) By following the same procedure as in Reference Ex.
2(c), (S) (T) -5-[(2-amino-2-methyl)ethyl]-2-methoxybenzene-sulfonamide was obtained by using (S)(-)-N-acetyl-5-[(2-amino-2-methyl)ethyl]-2-methoxybenzenesulfonamide as the starting material.
Melting point: 273-276C (decomposition Elemental analysis for ClOH17~lN2O3S:
C(%) H(%) N(%) Calcd.: 42.78 6.10 9.98 Found: 42.65 6.03 9.89 [~]24: 6.0 (c=l.01, methanol) '~ .
3LZ8Zq:~7 Example 1 2.8 g of 2-(o-ethoxyphenoxy)acetaldehyde diethyl acetal was dissolved in 20 ml of acet~ne, and after adding thereto 3 ml of 6N-hydrochloric acid, the mixture was stirred~for 1.5 hour at room temperature.
The solvent was distiled away and after adding water~to the residue, the precipitated oily material was extracted with ether. The ether extract was washed with water, and dried over anhydrous sodium sulfate. The solvent was distilled away to give oily residue. The residue was dissolved in 100 ml of methanol and fter adding ~~~ theretb R~ 5-(2-aminopropyl)-2-methoxybenzensulfonamide (2.4 g~, the mixture was refluxed under heating for 1 hour. After coo~ing, 0.25 g of platinum oxide catalyst was added, and the reaction mixtuxe was subjected ~o re~uction reaction by a usual manner. The catalyst was remove~ by filtration and after acidifying the filtxate with ~Cl-ethanol, the solvent was distilled away. The residue was recrystallized from methanol to give R(-)-5~[2-[[2-(o-ethoxyphenoxy)ethyl]amino]propyl]-2-methoxybenzensulfonamide ~Cl salt.
Melting point 228-230 C [~¦D -4.1 (methanol) 5~
:~
', Example 2 ~ y following the same procédure as in Example 1, by using S(+)-5-(2-aminopropyl-2-methoxybenzenesulfon-amide (instead of R(-)-5-(2waminopropyl)-2-methoxy benzenesulfonamide), 5(+)-5-[2-[~2-(o-ethoxyphenoxy)-ethyl]amino]propyl]-2-methcxybenze~esulfonamide HCl salt.
Melting point: 228-230C ~]24 +4 1 ~methanol) Example 3 By following the same procedure as in Example 1, by using racemic compound of 5-(2-aminopropyl)-2-methoxy-benzenesulfonamide (instead of R(-)-5-(2-aminopropyl)-2-methoxybenzenesulfon~lide), racemic compound of 5-[2-[[2-(o-ethoxyphenoxy)ethyl]amino]propyi]-2-methoxybenzene-sulfonamide RCl salt.
Melting point: 254-256~C
Examp~le 4 2.8 g of 2-(o ethoxyphenoxy)acetaldehyde diethyl acstal was dissolved in 20 ml of acetone, and after adding thereto 3 ml of 6N-hydrochloric acid, the resultant mixture was stirred at room temperature for 1.5 hour. The solvent was distilled away, and after adding water to the residue, the precipitated oily material was extracted with ether. The ether extract was washed with water, and dried over anhydrous sodium sulfate. The solvent was distiled awav to give oily residue. The residue was dissolved in 10~ ml of me~hanol and after adding thereto 2.4 g of R(~ (2-aminopropyl)-~'~8~
-2-methoxybenzenesulfonamide, the mixture was refluxed under heating for 1 hour. Then, sodium borohydride (0.42 g) was added to the mixture at 5-10C over a period of 1 hour, the mixture was allowed to stand overnight. The solvent ~as distilled away, and the residue was extracted with ethyl acetate. The extract was washed with water, and dried over anhydrous sodium sulfate. The solvent was distilled away, a~d the residue was treated with HC1-ethanol, and recrystallized from methanol to give R(-)-5-[2-[[2-(o-ethoxyphenoxy)ethyl]amino]propyl]-2-methoxybenzenesulfonamide HC1 salt.
Melting point: 228 230 C
[~]24 +4.1 tmethanol) D
Example 5 By following the same procedure as in Example 4, by using S(~)-5-(2-aminopropyl)-2-methoxybenzenesulfonamide (instead of R(-)-5-(2-aminopropyl)-2-methoxybenzene-sulfonamide), S(~)-5-[2-[[2-(o-ethoxyphenoxy)-ethyl]propyl]-2-methoxybenzenesulfonamide HC1 salt.
Melting point: 228 230C
[~]24 ~g.l (methanol) D
Example 6 By following the same procedure as in Example 4, by using racemic compound of 5 (2-aminopropyl)-2-methoxy-benzenesulfonamide (instead of R(-)-5-(2-aminopropyl)-2-methoxybenzenesulfonamide), racemic compound of 5-[2-[~2-~o-ethoxyphenoxy)ethyl]propyl]-2-methoxybenzene-sulfonamide HC1 salt. Melting point: i55_156 C.
Example 7 In 120 ml of ethanol were dissolved 2.4 g of (R)(-)~5-(2-aminopropyl)-2-methoxybenzenesulfonamide and 1.2 g of 2-~o-ethoxyphenoxy)ethyl bromide, and the mixture was refluxed for 16 hours under heating. The solvent was distilled away, and after alkalifing the residue by the addition of 10% sodium hydroxide, and the oily material precipitated was extraced with ethyl acetate. The extract solution was washed with a saturated aqueous sodium chloride, and dried over anhydrous magnesium sulfate. The solvent was distilled away, and the residue was subjected to column chromatography. The product was eluted with CHC13-methanol (9 5) to provide 1.5 g of the crude crystals of (R)(-)-5-[2-~[2-(o-ethoxyphenoxy)-ethyl]amino]-2-methylethyl]-2-methoxybenzenesulfonamide, which was treated with HC1-ethanol to give a hydrochloric acid salt of (R) ~ 5-[2-[[2-(o-ethoxyphenoxy)ethyl]-amino]propyl]-2-methoxybenzenesulfonamide.
Melting point: 228-230C
Elemental analysis for C~oH2gClN2OsS:
C~%) H(%) N(%) Calcd.: 53.99 6.57 6.30 Found: 53.90 6.64 6.27 [a]24: -4.0 (c=0.35, methanol) ~2~
Exzmple 8 By followina the same proced~re Jas in ExamDle 7 (S)( )-5-[2-[~2-(o-ethoxvphenoxv)ethvl]amino]-propyl]-2-methXyDenzenesulfcnamide HC1 salt was obtained by using (S)( )-5-[(2-aminopropyl) -- 2-methoxy-benzenesulfon2mide as the star~inc mzt~zl.
~elting point: 228-230C (met~anol~
Element~l analysis ~or C20-~29ClN2O5S:
C(~) H(%) N(~) Cacld.: 53.~9 6.57 6.30 Faund: 5:3-g2 6.57 6.~5 [~ 24 4 2 (c=0.36, methanol~
~ l 9 _ : --, .
137~
Example 9 3 ~ ~2CH HCH2CH2o ~
HCl 1) In 40 ml of water was dissolved R(-)-5-(2-amino-propyl)-2-methoxybenzenesulfonamide HCl salt (4 g) by heating, and after adding thereto 14 ml of a saturated aqueous potassium carbonate solution, the mixture was stirred at 5C for 2 hours. The precipitated crystals were collected by filtration,-and the crystals obtained weré recrystallized from ethanol to give 2.6 g of R(-~-5~(2-aminopropyl)-2-methaxybenzenesulfonamide.
Melting point: 166-167C
[~ ~23 -17.3 (c=1.07, methanol) 2) In 5 ml of N,N-dimelthylformamide were dissolved 976 mg of R(-)-5-(2-aminopropyl)-2-methoxybenzenesulfon-amide and 245 mg of 2-(o-ethoxyphenoxy)ethyl ~romide, and after heating the solution at 60C for 5-7 hours, the solvent was distilled away. To the residue was add-ed 28 ml of water, and the mixture was refluxed under heating for 30 minutes. The mixture was stirred at 5C for 1 hour, and the crystals precipita~ed during .he stirring were collected by filtration. The crystals collected were recrystalized from iso propanol to give 320 mg of R(~ [2-[[2-(o-ethoxyphenoxy)ethyl]amino]-: ;~. . _ .
, 32~7~7 propyl]-2-methoxybenzenesulfonamide. This product was dissolved in 9.6 ml of methanol while heati~g, and after acidifying the solution by addition of conc.
hydrochloric acid under heating, the mixture was stirred at 5C overnight. The orystals precipitated were collected by flltration to give 270 mg of R(-)-5-[2-1~2-(o-ethoxyphenoxy)ethyl]amino~propyl]-2-methoxybenzenesulfonamide HC1 salt.
Melting point: 227-230C
Elemental analysis for C20H29clN2o5s C(~ H~) N(~
Cacld. 53.98 6.57 6.30 Found: 54.01 6.35 6.27 [~ ]22 _4,~o (c=0.35, methanol) Example 10 S02N~I2 CH30~EI2CHNHCH2CH20 c~3 C2H5 HCl 3y following the same procedure as in Example 9, by using the corresponding S(~)-isomer instead of R(-)-5-(2-aminopropyl)-2-methoxybenzenesulfonamide, S(~)-5-[2-[[2-(o-ethoxyphenoxy)ethyl]amino~propyl]-2-methoxybenzenesulfonamide HCl salt was obtained.
Melting point: 228-230C
,, , , _ ~2~
Elemental analysis for C~0~29ClN205S
C(~) H(~) N(%) Cacld.: 53.98 6.57 6.30 Found: 53 90 6.55 6.29 [~]234.2 (c=0.36, methanol) --2~--. .
.
.
Claims (5)
1. A process for producing a compound of the following general formula (I) or a salt thereof (I) wherein R1 represents a lower alkyl group, a lower alkoxy group, or a hydroxyl group; R2 represents a hydrogen atom, or a lower alkyl group; R3 represents a hydrogen atom or z Lower alkyl group; and R4 represents a hydrogen atom, a lower alkyl group; a lower alkoxy group, or a hydroxyl group, which comprises reacting a compounf of the following formula (II) (II) (wherein R1, R2, and R3 are as defined above; and X1 and X2 represent a hydrogen atom or a protective group for an amino group) or a salt thereof with a substituted phenoxy compound (III) [wherein R4 represents a hydrogen atom, a lower alkyl group, a lower alkoxy group, a hydroxy group; and Y represents an aldehyde group which may be protected, or -CH2-Z- (Z
represents a removing group)] and then, if Y is an aldehyde group which may be protected, reducing the formed compound.
represents a removing group)] and then, if Y is an aldehyde group which may be protected, reducing the formed compound.
2. A process according to claim 1 wherein R1 is a lower alkoxy group, R2 is a lower alkyl group, R3 is a hydrogen atom, and R4 is a lower alkoxy group.
3. A process according to claim 1 or 2 for producing 5-[2-[[2-(o-ethoxyphenoxy)ethyl]amino]propyl]-2-methoxybenzensulfonamide or its salt which comprises reacting 5- (2-aminopropyl)-2-methoxybenzene-sulfonamide or its salt with a substituted phenoxy compound of the formula (IV) (wherein Ya represents a halogenomethyl group or an aldehyde group which may be protected), and then, if Y represents an aldehyde group which may be protected, reducing the formed compound.
4. A process according to claim 1 or 2 for producing R-(-)-5-[2-[[2-(o-ethoxyphenoxy)ethyl]aminol-propyl ]-2-methoxybenzenesulfonamide or its salt which comprises reacting R-(-)-5-(2-aminopropyl)- 2-methoxybenzenesulfonamide or its salt with a phenoxy compound of the formula (IV) (wherein Ya represents a halogenomethyl group or an aldehyde group which may be protected), and then, if Ya represents an aldehyde group which may be protected, reducing the formed compound,
5. A process according to claim 1 for producing each optically active compound of the formula (I) compound which comprises reacting each corresponding optically active compound of the formula (II) compound with the formula (III) compound.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP60254326A JPS62114952A (en) | 1985-11-13 | 1985-11-13 | Production of substituted phenethylamine derivative |
| JP254,326 | 1985-11-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1282077C true CA1282077C (en) | 1991-03-26 |
Family
ID=17263445
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000515041A Expired - Lifetime CA1282077C (en) | 1985-11-13 | 1986-07-31 | Process for producing substituted-phenethylamine derivatives |
Country Status (5)
| Country | Link |
|---|---|
| JP (1) | JPS62114952A (en) |
| KR (1) | KR940007746B1 (en) |
| AT (1) | AT397960B (en) |
| CA (1) | CA1282077C (en) |
| ES (1) | ES2000382A6 (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005080323A1 (en) * | 2004-02-23 | 2005-09-01 | Cadila Healthcare Limited | Process for manufacturing optically pure (r) or (s)-5-(2-aminopropyl)-2-methoxybenzene sulfonamide |
| WO2007031823A1 (en) * | 2005-09-12 | 2007-03-22 | Aurobindo Pharma Limited | An improved process for preparing tamsulosin hydrochloride |
| EP1786764A2 (en) | 2004-08-16 | 2007-05-23 | Scinopharm Singapore Pte Ltd. | Process for preparing tamsulosin |
| US7329780B2 (en) | 2003-12-09 | 2008-02-12 | Cj Corporation | Method of preparing optically pure phenethylamine derivatives |
| WO2008152653A3 (en) * | 2007-06-11 | 2010-04-29 | Matrix Laboratories Ltd | An improved process for the preparation of tamsulosin hydrochloride |
| JP2013504563A (en) * | 2009-09-12 | 2013-02-07 | サンド・アクチエンゲゼルシヤフト | Process for the preparation of indoline derivatives and intermediates thereof |
| DE202023102187U1 (en) | 2023-04-25 | 2023-05-02 | Nusrath Anjum | Derivative formulation based on tamsulosin |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4971990A (en) * | 1988-02-19 | 1990-11-20 | Hokuriku Pharmaceutical Co., Ltd. | Phenoxyethylamine derivatives, for preparing the same and composition for exhibiting excellent α1 -blocking activity containing the same |
| US5288759A (en) * | 1992-08-27 | 1994-02-22 | Alcon Laboratories, Inc. | Use of certain sulfamoyl-substituted phenethylamine derivatives to reverse drug-induced mydriasis |
| TW536402B (en) | 1998-06-26 | 2003-06-11 | Yamanouchi Pharma Co Ltd | Pharmaceutical composition for the therapy of voiding dysfunction |
| KR100525493B1 (en) * | 2001-02-23 | 2005-11-02 | 연성정밀화학(주) | Process for preparing sulfamoyl-substituted phenethylamine derivatives |
| CZ20013848A3 (en) * | 2001-10-25 | 2003-05-14 | Léčiva, A.S. | Process for preparing (R)-(-)-5-[2-[2-(2-ethoxyphenoxy)ethylamino]propyl]-2-methoxybenzene sulfonamide |
| ES2200699B1 (en) | 2002-07-12 | 2005-10-01 | Ragactives, S.L | PROCEDURE FOR THE SEPARATION OF R (-) AND S (+) - 5- (2 - ((2- (ETOXIFENOXI) ETIL) AMINO) PROPIL-2-METOXIBENCENO-SULFONAMIDE. |
| WO2004016582A1 (en) * | 2002-08-14 | 2004-02-26 | Natco Pharma Limited | An improved process for the preparation of tamsulosin hydrochloride |
| KR100503639B1 (en) | 2003-02-12 | 2005-07-26 | 보령제약 주식회사 | A purification process of Tamsulosin |
| SI21655A (en) * | 2003-12-29 | 2005-06-30 | LEK farmacevtska dru�ba d.d. | Synthesis of optically pure (r)-5-(2-aminopropyl)-methoxybenzene sulphonamide |
| SI21656A (en) * | 2003-12-29 | 2005-06-30 | LEK farmacevtska družba d.d. | Preparation of (r)-5-(2-(2-(2-ethoxyphenoxy)ethylamino)-1-propyl)-2-methoxybenzene sulphonamide hydrochloride of high chemical purity |
| CZ2004197A3 (en) | 2004-02-05 | 2005-08-17 | Zentiva, A. S. | Process for preparing (R)-(-)-5-(2-aminopropyl)-2-methoxybenzenesulfonamide |
| JP4800213B2 (en) * | 2004-07-07 | 2011-10-26 | 浜理薬品工業株式会社 | Process for producing optically active phenylpropylamine derivatives |
| BRPI1007484B1 (en) | 2009-02-04 | 2019-04-16 | Astellas Pharma Inc. | PHARMACEUTICAL COMPOSITION FORMED ORAL ADMINISTRATION UNDERSTANDING A LAYER UNDERSTANDING A MODIFIED RELEASE PART AND A LAYER UNDERSTANDING AN IMMEDIATE RELEASE PART |
| EP2255793A1 (en) | 2009-05-28 | 2010-12-01 | Krka Tovarna Zdravil, D.D., Novo Mesto | Pharmaceutical composition comprising tamsulosin |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1147342A (en) * | 1977-10-12 | 1983-05-31 | Kazuo Imai | Process of producing novel phenylethanolamine derivatives |
| JPS56110665A (en) * | 1980-02-08 | 1981-09-01 | Yamanouchi Pharmaceut Co Ltd | Sulfamoyl-substituted phenetylamine derivative and its preparation |
| US4558156A (en) * | 1980-02-08 | 1985-12-10 | Yamanouchi Pharmaceutical Co., Ltd. | Sulfamoyl-substituted phenethylamine derivatives |
-
1985
- 1985-11-13 JP JP60254326A patent/JPS62114952A/en active Granted
-
1986
- 1986-07-07 KR KR1019860005460A patent/KR940007746B1/en not_active Expired - Lifetime
- 1986-07-28 AT AT0203286A patent/AT397960B/en not_active IP Right Cessation
- 1986-07-29 ES ES8600685A patent/ES2000382A6/en not_active Expired
- 1986-07-31 CA CA000515041A patent/CA1282077C/en not_active Expired - Lifetime
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7329780B2 (en) | 2003-12-09 | 2008-02-12 | Cj Corporation | Method of preparing optically pure phenethylamine derivatives |
| WO2005080323A1 (en) * | 2004-02-23 | 2005-09-01 | Cadila Healthcare Limited | Process for manufacturing optically pure (r) or (s)-5-(2-aminopropyl)-2-methoxybenzene sulfonamide |
| EP1786764A2 (en) | 2004-08-16 | 2007-05-23 | Scinopharm Singapore Pte Ltd. | Process for preparing tamsulosin |
| EP1786764B1 (en) * | 2004-08-16 | 2017-03-15 | Scinopharm Singapore Pte Ltd. | Process for preparing tamsulosin |
| WO2007031823A1 (en) * | 2005-09-12 | 2007-03-22 | Aurobindo Pharma Limited | An improved process for preparing tamsulosin hydrochloride |
| US8273918B2 (en) | 2005-09-12 | 2012-09-25 | Avrobindo Pharma Ltd. | Process for preparing tamsulosin hydrochloride |
| WO2008152653A3 (en) * | 2007-06-11 | 2010-04-29 | Matrix Laboratories Ltd | An improved process for the preparation of tamsulosin hydrochloride |
| JP2013504563A (en) * | 2009-09-12 | 2013-02-07 | サンド・アクチエンゲゼルシヤフト | Process for the preparation of indoline derivatives and intermediates thereof |
| DE202023102187U1 (en) | 2023-04-25 | 2023-05-02 | Nusrath Anjum | Derivative formulation based on tamsulosin |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0137391B2 (en) | 1989-08-07 |
| KR940007746B1 (en) | 1994-08-24 |
| ATA203286A (en) | 1993-12-15 |
| KR870004949A (en) | 1987-06-02 |
| ES2000382A6 (en) | 1988-02-16 |
| AT397960B (en) | 1994-08-25 |
| JPS62114952A (en) | 1987-05-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1282077C (en) | Process for producing substituted-phenethylamine derivatives | |
| JPH052678B2 (en) | ||
| JP2004530638A (en) | Crystalline venlafaxine base, a novel polymorphic form of venlafaxine hydrochloride, and a method for preparing the same | |
| TWI796701B (en) | Stereoselective synthesis of intermediate for preparation of heterocyclic compound | |
| JPH0662519B2 (en) | Method for producing phenol ether using cyclic intermediate | |
| CZ1494A3 (en) | Process for preparing diphenyl derivatives, aromatic compound and its use | |
| CN106573886B (en) | Method for producing cyclic alpha-ketols from cyclic alpha-ketoenols | |
| JP2015151395A (en) | Method of preparing adrenergic antagonist | |
| JP6851149B2 (en) | Method for producing piperidine compound | |
| JP2006514651A (en) | 1-alkyl-3-aminoindazole | |
| JPS58189132A (en) | Manufacture of butene derivative | |
| JPH0368569A (en) | Preparation of substituted ethenes | |
| ES2330479T3 (en) | PROCEDURE FOR THE PREPARATION OF DULOXETINE. | |
| JPS5915901B2 (en) | Method for producing u↓-amino alcohol | |
| WO2016146040A1 (en) | Industrial method for production of 3,7-di-tert-butyl-s-(trifluoromethyl)dibenzothiophenium trifluoromethanesulfonate | |
| JPS6225666B2 (en) | ||
| TW200405809A (en) | Process for preparing (S)-(+)-2-(substituted phenyl)-2-hydroxy-ethyl carbamates | |
| JPH02290851A (en) | Production of 2-chloru-5-aminomethylpyridine | |
| JPH0472818B2 (en) | ||
| JP2001520646A (en) | New manufacturing method | |
| CN1910180B (en) | Process for the preparation of 2-(ethoxymethyl)-tropane derivatives | |
| TWI361807B (en) | Process for preparing substituted 4-alkoxycarbonyl-3-aminothiophenes | |
| JP3069810B2 (en) | Method for producing (3-fluoropyridin-2-yloxy) phenoxypropionic acid | |
| JP7128629B2 (en) | Method for producing lubiprostone | |
| JPH06102656B2 (en) | Ranitidine manufacturing method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry |